Sanford C. Bernstein set a €30.00 ($34.88) price objective on Evonik Industries (FRA:EVK) in a research note published on Tuesday morning, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.
A number of other analysts also recently issued reports on the company. Warburg Research set a €36.00 ($41.86) price objective on Evonik Industries and gave the stock a buy rating in a research note on Thursday, August 1st. Goldman Sachs Group reaffirmed a sell rating and issued a price objective on shares of Evonik Industries in a research note on Monday, November 4th. HSBC set a €25.00 ($29.07) price objective on Evonik Industries and gave the stock a neutral rating in a research note on Wednesday, September 18th. Independent Research set a €25.00 ($29.07) price objective on Evonik Industries and gave the stock a neutral rating in a research note on Wednesday, August 7th. Finally, JPMorgan Chase & Co. set a €26.00 ($30.23) price objective on Evonik Industries and gave the stock a neutral rating in a research note on Thursday, August 1st. Four investment analysts have rated the stock with a sell rating, eight have assigned a hold rating and nine have assigned a buy rating to the stock. Evonik Industries presently has a consensus rating of Hold and an average price target of €28.30 ($32.91).
FRA:EVK opened at €26.22 ($30.49) on Tuesday. Evonik Industries has a 1 year low of €26.78 ($31.14) and a 1 year high of €32.97 ($38.34). The stock’s 50 day simple moving average is €23.31 and its two-hundred day simple moving average is €24.31.
About Evonik Industries
Evonik Industries AG engages in the specialty chemicals business worldwide. It operates through Nutrition & Care, Resource Efficiency, Performance Materials, and Services segments. The Nutrition & Care segment offers specialty chemicals, including amphoteric surfactants, ceramides, phytosphingosines, oleochemicals, quaternary derivatives, polyurethane additives, organically modified silicones, superabsorbents, amino acids and amino acid derivatives, synthesis products, pharmaceutical polymers, and DL-methionine for use in consumer goods, and animal nutrition and healthcare products.
Featured Story: How to Invest in Growth Stocks
Receive News & Ratings for Evonik Industries Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evonik Industries and related companies with MarketBeat.com's FREE daily email newsletter.